Advertisement
U.S. markets open in 9 hours 16 minutes

Aerovate Therapeutics, Inc. (AVTE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.6600+0.0500 (+1.92%)
At close: 04:00PM EST
2.6600 0.00 (0.00%)
After hours: 04:20PM EST
Full screen
Loading interactive chart...
  • BioPharma Dive

    Jade, another biotech spinout of Paragon, to merge with Aerovate

    The immune disease drug developer expects to raise $300 million in a private financing set to close before its combination with the struggling Aerovate.

  • GlobeNewswire

    Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

    Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to redefine the standard of care for patients with autoimmune diseases Jade Biosciences, the fourth company founded on assets licensed from Paragon Therapeutics, expects to initiate a clinical trial for JADE-001 in the second half of 2025 Approximately $300 million raised to date, including anticipated proceeds from an oversubscribed pre-closing private financing, expected to fund operations t